Mark S. Forman

13.3k citations
91 papers · 11.1k · 4 hit papers · h-index 49

Impact in

  • Neurology top 0.1%
    • Amyotrophic Lateral Sclerosis Research
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological diseases and metabolism
  • Physiology top 0.2%
    • Alzheimer's disease research and treatments

Papers in

    • Parkinson's Disease Mechanisms and Treatments 22
    • Amyotrophic Lateral Sclerosis Research 18
    • Neurological disorders and treatments 8
    • Neurological diseases and metabolism 7
    • Alzheimer's disease research and treatments 37

Mark S. Forman

90 papers receiving 10.7k citations

Mark S. Forman's Hit Papers

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients 2016 · 374 citations
3740+7+15Years since publication250500750

Peers

Mark S. Forman
Comparison fields: 5 of 144
  • Neurology 5.1k
  • Neurology 1.8k
  • Physiology 4.3k
  • Genetics 1.1k
  • Psychiatry and Mental health 1.3k
Replace Jean‐Jacques Martin with:
Jean‐Jacques Martin Belgium
Richard Crook United States
Thomas Arzberger Germany
Tetsuaki Arai Japan
Michael L. Hutton United States
Roberta Ghidoni Italy
Mike Hutton United States
Luisa Benussi Italy
Jill R. Murrell United States
Alice S. Chen‐Plotkin United States
Mark S. Forman relative to Jean‐Jacques Martin Belgium Jean‐Jacques Martin's profile →
Citations per field
00.5×1.5×
Jean‐Jacques Martin · 1×
Citations per year

Countries citing papers authored by Mark S. Forman

Since Specialization
Citations

This map shows the geographic impact of Mark S. Forman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Forman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Forman more than expected).

Fields of papers citing papers by Mark S. Forman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Forman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Forman. The network helps show where Mark S. Forman may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Forman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Forman Line = papers co-authored together Mark S. Forman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
Hit paper breakdown →
2007820
2
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Hit paper breakdown →
2003765
3 2004583
4 2005497
5
Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies
Hit paper breakdown →
2009489
6 2007453
7 2006414
8 1997398
9
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
Hit paper breakdown →
2016374
10 2008341
11 2005334
12 2007286
13 2008257
14 2007232
15 2005230
16 2010225
17 2006217
18 2006186
19 2008186
20 2007174

About Mark S. Forman

Mark S. Forman is a scholar working on Neurology, Physiology, Neurology, Cellular and Molecular Neuroscience and Pharmacology, having authored 91 papers that have together received 11.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (37 papers), Parkinson's Disease Mechanisms and Treatments (22 papers), Amyotrophic Lateral Sclerosis Research (18 papers), Cholinesterase and Neurodegenerative Diseases (12 papers), Genetic Neurodegenerative Diseases (10 papers), Computational Drug Discovery Methods (9 papers), Neurological disorders and treatments (8 papers) and Neurological diseases and metabolism (7 papers). The work is most often cited by research in Neurology (5.1k citations), Neurology (1.8k citations), Physiology (4.3k citations), Genetics (1.1k citations) and Psychiatry and Mental health (1.3k citations). Mark S. Forman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, Manuela Neumann, Hans A. Kretzschmar, Bruce Leonard Miller, Makoto Higuchi, Linda K. Kwong, Christopher M. Clark, Benoit I. Giasson and Murray Grossman. Their work appears in journals such as Alzheimer s & Dementia, Journal of Neuropathology & Experimental Neurology, Journal of Neuroscience, Neurology and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact